Conference
KeyVibe-003: Randomized, double-blind, phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1-positive metastatic NSCLC
Authors
Cho BC; Juergens RA; Cheng Y; de Castro G; Erman M; Bauman JR; Takahashi T; Schwarzenberger P; Li C; Pietanza MC
Volume
82
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
June 15, 2022
Name of conference
Annual Meeting of the American-Association-for-Cancer-Research (AACR)
Conference place
LA, New Orleans
Conference start date
April 8, 2022
Conference end date
April 13, 2022
Conference proceedings
CANCER RESEARCH
Issue
12
ISSN
0008-5472